Stock DUL ALNYLAM PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Alnylam Pharmaceuticals, Inc. BOERSE MUENCHEN

Equities

DUL

US02043Q1076

Real-time BOERSE MUENCHEN
Other stock markets
 03:43:21 28/06/2024 pm IST 		5-day change 1st Jan Change
229.4 EUR -0.52% Intraday chart for Alnylam Pharmaceuticals, Inc. +57.46% +30.28%
27/06 Stifel Adjusts Price Target on Alnylam Pharmaceuticals to $295 From $215, Maintains Buy Rating MT
27/06 RBC Raises Price Target on Alnylam Pharmaceuticals to $265 From $250, Keeps Outperform Rating MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. ALNY Stock
  4. DUL Stock
  5. Revisions Alnylam Pharmaceuticals, Inc.